Arzneimittel-Forschung 1985-01-01

Calcium antagonistic properties of nicardipine, a dihydropyridine derivative assessed in isolated cerebral arteries and cardiac muscle.

K Nakayama, J Kurihara, Y Miyajima, K Ishii, H Kato

Index: Arzneimittelforschung 35(4) , 687-93, (1985)

Full Text: HTML

Abstract

Calcium antagonistic properties of nicardipine (YC-93), a 1,4-dihydropyridine derivative, were studied in isolated cerebral artery and cardiac tissues of rabbits and dogs. Calcium antagonism was assessed in electrically stimulated rabbit basilar artery. Nicardipine at 10(-7) mol/l shifted to the right the dose-response curve for Ca of the phasic contraction evoked by electrical stimulation with an alternating current, and at higher concentration it reduced the maximum tension and slope of the dose-response curve. Nicardipine inhibited the augmented contraction produced by high K, k-strophanthin and 5-hydroxytryptamine. It also caused dose-dependent inhibition of 45Ca uptake enhanced by 80 mmol/l K in dog basilar artery, and had a slight effect on the resting 45Ca uptake. In rabbit basilar artery treated with saponin, nicardipine in a dose of 10(-5) mol/l had no apparent effect on the increase in tension induced by excess Ca. Nicardipine had negative inotropic and chronotropic actions. These results suggest that nicardipine, like nifedipine, has a relative high vascular selectivity, and primarily acts by inhibiting Ca influx through the plasma membrane of vascular and cardiac tissues.


Related Compounds

Related Articles:

Increased in vivo synthesis of retinal Na pump isoforms after pre-treatment with citrate buffer.

1988-01-01

[Prog. Clin. Biol. Res. 268B , 143-7, (1988)]

[Determination of zimarin in urine].

1989-01-01

[Sud. Med. Ekspert. 32(2) , 35-6, (1989)]

[Validity of cardioactive glycosides].

1992-10-01

[Minerva Anestesiol. 58(10) , 639-45, (1992)]

Activatory effect of two cardioglycosides on Cavia cobaya kidney Na+/K+-ATPase activity.

1985-01-01

[Gen. Pharmacol. 16(3) , 183-8, (1985)]

[Pharmacologic modification of diastolic ventricular function in patients with coronary heart disease].

1986-11-30

[Wien. Med. Wochenschr. 136(21-22) , 545-9, (1986)]

More Articles...